Organization
Augurex, Vancouver, Canada
4 abstracts
Abstract
14-3-3ETA BIOMARKER DYNAMICS IN CIA MARK DISEASE SEVERITY IN A NON-INTERVENTIONAL STUDY Org: National Research Council, Ottawa, U of Alberta, Edmonton, Augurex, Vancouver, Canada,
Abstract
14-3-3ETA PREDICTS RADIOGRAPHIC PROGRESSION IN RECENT-ONSET POLYARTHRITIS PATIENTS Org: U de Sherbrooke, Quebec, Augurex, Vancouver, Canada, U of Alberta, Edmonton, Canada,
Abstract
AUTO-ANTIBODIES TO A SPECIFIC 14-3-3ETA EPITOPE IS A MARKER OF ANKYLOSING SPONDYLITIS, IS ASSOCIATED WITH SIJ INFLAMMATION AND PREDICTS RADIOGRAPHIC PROGRESSION Org: U of Alberta, Edmonton, Augurex, Vancouver, Canada,
Abstract
93% OF EARLY RA PATIENTS ARE POSITIVE FOR 14-3-3ETA MARKERS AND 14-3-3ETA AUTO-ANTIBODIES INFORM A FAVOURABLE PROGNOSIS, IRRESPECTIVE OF RF OR ACPA STATUS Org: Reade, Amsterdam, Netherlands, Augurex, Vancouver, Canada, Reade, Netherlands, Canada, Hosp Spec Surg, New York, United States, Mt Sinai Hosp, Toronto,